I don’t have PM but I expect some of the following based on my conversation with the company:
Additional patents to be issued Institutional investors coming in as the company is talking to them now that fda gave them the green light. Oppenheimer is a name and wouldn’t be surprised to see baker brothers. Fast track designation. Company does not want to partner now because they are very excited about their drug and feel they wouldn’t get the best possible deal now. Oral drug if it works is huge. I compared vtgn to acad and person I spoke to agreed. No planned reverse split. Company extremely disappointed with stock price but feel it’s just a short attacking because everything is going great. FDA was very happy with what they are seeing with the company
News 
Market Data 
Discover 
